Mizuki Onozawa

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 06, 2026
Deferred Cytoreductive Nephrectomy With Partial Hepatectomy for Giant Renal Cell Carcinoma of the Right Kidney With Extensive Hepatic Invasion: A Case Report in the Era of Systemic Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.

|Jul 06, 2023
A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy.

Satoru Taguchi, Mizuki Onozawa, Shiro Hinotsu

|Sep 23, 2022
Improved survival of poor-risk non-seminomatous germ cell tumor patients: real-world data from a single institute in Japan.

Kozaburo Tanuma, Koji Kawai, Satoshi Nitta

|Mar 19, 2021
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries.

Jasmine Lim, Mizuki Onozawa, Marniza Saad

|Oct 24, 2020
Modified J-CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy.

Jasmine Lim, Shiro Hinotsu, Mizuki Onozawa

|Aug 29, 2018
Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching.

Mizuki Onozawa, Hideyuki Akaza, Shiro Hinotsu

Pageof 1

Frequent Collaborators

2 joint publications

Jasmine Lim

2 joint publications

Teng-Aik Ong

2 joint publications

Jun Miyazaki

1 joint publications

Satoshi Nitta